Wockhardt third-quarter profit falls 29 percent

MUMBAI Mon Feb 10, 2014 9:37am IST

Pharmaceutical tablets and capsules in foil strips are arranged on a table in this picture illustration taken in Ljubljana September 18, 2013. REUTERS/Srdjan Zivulovic/Files

Pharmaceutical tablets and capsules in foil strips are arranged on a table in this picture illustration taken in Ljubljana September 18, 2013.

Credit: Reuters/Srdjan Zivulovic/Files

Related Topics

Stocks

   

MUMBAI (Reuters) - Wockhardt Ltd(WCKH.NS) reported a 29 percent drop in quarterly net profit, hit by a fall in sales after the U.S. health regulator banned two of the drugmaker's plants from exporting products to the United States - its largest market.

In November, the U.S. Food and Drug Administration issued an import alert, effectively a ban, against Wockhardt's Chikalthana plant in western India. The FDA had imposed a ban on the company's Waluj plant in May.

Wockhardt's net profit in the third quarter fell to 3.04 billion rupees from 4.28 billion rupees a year earlier, the company said in a statement late on Sunday. Total sales dropped 14 percent to 12.37 billion rupees.

The company's U.S. business, which accounts for 44 percent of revenue, fell 30 percent in the quarter.

(Reporting by Sumeet Chatterjee; Editing by Supriya Kurane)

FILED UNDER:

Reuters Showcase

HCL Technologies

HCL Technologies

Software services exporter posts 28 pct rise in Q2 profit  Full Article 

Google Revenue

Google Revenue

Fourth-qtr revenue misses Wall Street target  Full Article 

Uber's Woes

Uber's Woes

Uber, other taxi-hailing apps hit new roadblock in Delhi.  Full Article 

Transfer Pricing

Transfer Pricing

India's Vodafone decision eases tax worries for Shell, others.  Full Article 

Renewable Energy

Renewable Energy

NTPC bars foreign bids for three solar projects  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage